Mucoepidermoid carcinoma of the salivary glands revisited with special reference to histologic grading and CRTC1/3-MAML2 genotyping
Open Access
- 6 July 2021
- journal article
- research article
- Published by Springer Science and Business Media LLC in Virchows Archiv
- Vol. 479 (5), 975-985
- https://doi.org/10.1007/s00428-021-03146-x
Abstract
Mucoepidermoid carcinoma (MEC) is the most common carcinoma of the salivary glands. Here, we have used two large patient cohorts with MECs comprising 551 tumors to study clinical, histological, and molecular predictors of survival. One cohort (n = 167), with known CRCT1/3-MAML2 fusion status, was derived from the Hamburg Reference Centre (HRC; graded with the AFIP and Brandwein systems) and the other (n = 384) was derived from the population-based Cancer Registry of North Rhine-Westphalia (LKR-NRW; graded with the AFIP system). The reliability of both the AFIP and Brandwein grading systems was excellent (n = 155). The weighted kappa for inter-rater agreement was 0.81 (95% CI 0.65-0.97) and 0.83 (95% CI 0.71-0.96) for the AFIP and Brandwein systems, respectively. The 5-year relative survival was 79.7% (95% CI 73.2-86.2%). Although the Brandwein system resulted in a higher rate of G3-MECs, survival in G3-tumors (AFIP or Brandwein grading) was markedly worse than in G1/G2-tumors. Survival in > T2 tumors was markedly worse than in those with lower T-stage. Also, fusion-negative MECs had a worse 5-year progression-free survival. The frequency of fusion-positive MECs in the HRC cohort was 78.4%, of which the majority (86.7%) was G1/G2-tumors. In conclusion, the AFIP and Brandwein systems are useful in estimating prognosis and to guide therapy for G3-MECs. However, their significance regarding young age (<= 30 years) and location-dependent heterogeneity of in particular G2-tumors is more questionable. We conclude that CRTC1/3-MAML2 testing is a useful adjunct to histologic scoring of MECs and for pinpointing tumors with poor prognosis with higher precision, thus avoiding overtreatment.Keywords
Funding Information
- German Federal Ministry of Education and Science (01ER1704)
- Swedish state under the agreement between the Swedish government and the country councils (ALFGBG-721711)
- University of Gothenburg
This publication has 39 references indexed in Scilit:
- P63 expression in papillary cystadenoma and mucoepidermoid carcinoma of minor salivary glandsOral Surgery, Oral Medicine, Oral Pathology and Oral Radiology, 2013
- Sinonasal Tract Mucoepidermoid Carcinoma: A Clinicopathologic and Immunophenotypic Study of 19 Cases Combined with a Comprehensive Review of the LiteratureHead and Neck Pathology, 2011
- A Reappraisal of the MECT1/MAML2 Translocation in Salivary Mucoepidermoid CarcinomasThe American Journal of Surgical Pathology, 2010
- Clinicopathological significance of the CRTC3–MAML2 fusion transcript in mucoepidermoid carcinomaLaboratory Investigation, 2009
- A link between the expression of the stem cell marker HMGA2, grading, and the fusion CRTC1‐MAML2 in mucoepidermoid carcinomaGenes, Chromosomes and Cancer, 2009
- An Update on Grading of Salivary Gland CarcinomasHead and Neck Pathology, 2009
- Treatment and survival outcomes based on histologic grading in patients with head and neck mucoepidermoid carcinomaCancer, 2008
- Up‐to‐date cancer survival: Period analysis and beyondInternational Journal of Cancer, 2008
- The MECT1-MAML2 Gene Fusion and Benign Warthin's Tumor: Is the MECT1-MAML2 Gene Fusion Specific to Mucuepidermoid Carcinoma?The Journal of Molecular Diagnostics, 2006
- Period analysis for ‘up-to-date’ cancer survival dataEuropean Journal Of Cancer, 2004